메뉴 건너뛰기




Volumn 20, Issue 7, 2015, Pages 784-789

Target selection for FDA-approved medicines

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR THERAPY AGENT; NEW DRUG; CARRIER PROTEIN; CELL RECEPTOR; DRUG; G PROTEIN COUPLED RECEPTOR; ION CHANNEL;

EID: 84936776867     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.11.001     Document Type: Short Survey
Times cited : (26)

References (28)
  • 2
    • 0024396459 scopus 로고
    • Drugs from emasculated hormones: the principle of syntopic antagonism
    • J. Black Drugs from emasculated hormones: the principle of syntopic antagonism Science 245 1989 486 493
    • (1989) Science , vol.245 , pp. 486-493
    • Black, J.1
  • 4
    • 84906303552 scopus 로고    scopus 로고
    • An overview of FDA-approved new molecular entities: 1827-2013
    • M.S. Kinch An overview of FDA-approved new molecular entities: 1827-2013 Drug Discov. Today 19 2014 1033 1039
    • (2014) Drug Discov. Today , vol.19 , pp. 1033-1039
    • Kinch, M.S.1
  • 5
    • 77955578752 scopus 로고    scopus 로고
    • Beta blockers in hypertension
    • author reply 415-416
    • J.M. Cruickshank Beta blockers in hypertension Lancet 376 2010 415 author reply 415-416.
    • (2010) Lancet , vol.376 , pp. 415
    • Cruickshank, J.M.1
  • 6
    • 84910654115 scopus 로고    scopus 로고
    • Trends in pharmaceutical targeting of clinical indications: 1930-2013
    • M.S. Kinch Trends in pharmaceutical targeting of clinical indications: 1930-2013 Drug Discov. Today 2014 doi: 10.1016/j.drudis.2014.05.021
    • (2014) Drug Discov. Today
    • Kinch, M.S.1
  • 7
    • 0020370796 scopus 로고
    • Calcium entry blockers: uses and implications for anesthesiologists
    • J.G. Reves Calcium entry blockers: uses and implications for anesthesiologists Anesthesiology 57 1982 504 518
    • (1982) Anesthesiology , vol.57 , pp. 504-518
    • Reves, J.G.1
  • 8
    • 0016646573 scopus 로고
    • Possible involvement of GABA in the central actions of benzodiazepines
    • W. Haefely Possible involvement of GABA in the central actions of benzodiazepines Adv. Biochem. Psychopharmacol. 14 1975 131 151
    • (1975) Adv. Biochem. Psychopharmacol. , vol.14 , pp. 131-151
    • Haefely, W.1
  • 9
    • 0016904516 scopus 로고
    • Insights into protein biosynthesis and ribosome function through inhibitors
    • S. Pestka Insights into protein biosynthesis and ribosome function through inhibitors Prog. Nucleic Acid Res. Mol. Biol. 17 1976 217 245
    • (1976) Prog. Nucleic Acid Res. Mol. Biol. , vol.17 , pp. 217-245
    • Pestka, S.1
  • 10
    • 84907815937 scopus 로고    scopus 로고
    • An analysis of FDA-approved drugs for infectious disease: antibacterial agents
    • M.S. Kinch An analysis of FDA-approved drugs for infectious disease: antibacterial agents Drug Discov. Today 19 2014 1283 1287
    • (2014) Drug Discov. Today , vol.19 , pp. 1283-1287
    • Kinch, M.S.1
  • 11
    • 84885102013 scopus 로고    scopus 로고
    • Approval and withdrawal of new antibiotics and other antiinfectives in the US, 1980-2009
    • K. Outterson Approval and withdrawal of new antibiotics and other antiinfectives in the US, 1980-2009 J. Law Med. Ethics 41 2013 688 696
    • (2013) J. Law Med. Ethics , vol.41 , pp. 688-696
    • Outterson, K.1
  • 12
    • 84919395951 scopus 로고    scopus 로고
    • An analysis of FDA-approved drugs for oncology
    • M.S. Kinch An analysis of FDA-approved drugs for oncology Drug Discov. Today 2014 doi: 10.1016/j.drudis.2014.08.007
    • (2014) Drug Discov. Today
    • Kinch, M.S.1
  • 13
    • 0025618812 scopus 로고
    • From cloning to a commercial realization: human alpha interferon
    • E. Baron, and S. Narula From cloning to a commercial realization: human alpha interferon Crit. Rev. Biotechnol. 10 1990 179 190
    • (1990) Crit. Rev. Biotechnol. , vol.10 , pp. 179-190
    • Baron, E.1    Narula, S.2
  • 15
    • 0017128012 scopus 로고
    • Converting enzyme inhibition and blood pressure regulation
    • A.C. Barger Converting enzyme inhibition and blood pressure regulation Agents Actions 6 1976 538 542
    • (1976) Agents Actions , vol.6 , pp. 538-542
    • Barger, A.C.1
  • 16
    • 0025552182 scopus 로고
    • HIV-1 protease as a potential target for anti-AIDS therapy
    • T.D. Meek, and G.B. Dreyer HIV-1 protease as a potential target for anti-AIDS therapy Ann. N. Y. Acad. Sci. 616 1990 41 53
    • (1990) Ann. N. Y. Acad. Sci. , vol.616 , pp. 41-53
    • Meek, T.D.1    Dreyer, G.B.2
  • 17
    • 0001650127 scopus 로고
    • Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A
    • S. Seelmeier Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A Proc. Natl. Acad. Sci. U. S. A. 85 1988 6612 6616
    • (1988) Proc. Natl. Acad. Sci. U. S. A. , vol.85 , pp. 6612-6616
    • Seelmeier, S.1
  • 18
    • 77956369648 scopus 로고    scopus 로고
    • Drug development for cancer chemoprevention: focus on molecular targets
    • K.A. Johnson, and P.H. Brown Drug development for cancer chemoprevention: focus on molecular targets Semin. Oncol. 37 2010 345 358
    • (2010) Semin. Oncol. , vol.37 , pp. 345-358
    • Johnson, K.A.1    Brown, P.H.2
  • 19
    • 84887893900 scopus 로고    scopus 로고
    • Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches
    • J.A. Lee, and E.L. Berg Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches J. Biomol. Screen. 18 2013 1143 1155
    • (2013) J. Biomol. Screen. , vol.18 , pp. 1143-1155
    • Lee, J.A.1    Berg, E.L.2
  • 20
    • 84875448716 scopus 로고    scopus 로고
    • Phenotypic vs. target-based drug discovery for first-in-class medicines
    • D.C. Swinney Phenotypic vs. target-based drug discovery for first-in-class medicines Clin. Pharmacol. Ther. 93 2013 299 301
    • (2013) Clin. Pharmacol. Ther. , vol.93 , pp. 299-301
    • Swinney, D.C.1
  • 22
    • 77952552641 scopus 로고    scopus 로고
    • Cheminformatics approaches to analyze diversity in compound screening libraries
    • L.B. Akella, and D. DeCaprio Cheminformatics approaches to analyze diversity in compound screening libraries Curr. Opin. Chem. Biol. 14 2010 325 330
    • (2010) Curr. Opin. Chem. Biol. , vol.14 , pp. 325-330
    • Akella, L.B.1    Decaprio, D.2
  • 23
    • 67650299761 scopus 로고    scopus 로고
    • Quantifying biogenic bias in screening libraries
    • J. Hert Quantifying biogenic bias in screening libraries Nat. Chem. Biol. 5 2009 479 483
    • (2009) Nat. Chem. Biol. , vol.5 , pp. 479-483
    • Hert, J.1
  • 24
    • 33747754105 scopus 로고    scopus 로고
    • Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse
    • T.K. Bjarnadottir Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse Genomics 88 2006 263 273
    • (2006) Genomics , vol.88 , pp. 263-273
    • Bjarnadottir, T.K.1
  • 26
    • 70350038016 scopus 로고    scopus 로고
    • Mapping the human membrane proteome: a majority of the human membrane proteins can be classified according to function and evolutionary origin
    • M.S. Almén Mapping the human membrane proteome: a majority of the human membrane proteins can be classified according to function and evolutionary origin BMC Biol. 7 2009 50
    • (2009) BMC Biol. , vol.7 , pp. 50
    • Almén, M.S.1
  • 27
    • 0035479253 scopus 로고    scopus 로고
    • How many nuclear hormone receptors are there in the human genome?
    • M. Robinson-Rechavi How many nuclear hormone receptors are there in the human genome? Trends Genet. 17 2001 554 556
    • (2001) Trends Genet. , vol.17 , pp. 554-556
    • Robinson-Rechavi, M.1
  • 28
    • 79957957725 scopus 로고    scopus 로고
    • Strategies in the rational drug design
    • T. Mavromoustakos Strategies in the rational drug design Curr. Med. Chem. 18 2011 2517 2530
    • (2011) Curr. Med. Chem. , vol.18 , pp. 2517-2530
    • Mavromoustakos, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.